Global Prophylactic HIV Drugs Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

Segmented by Drug;

Tenofovir, Emtricitabine and Other.

Segmented by Dosage Form;

Oral and Topical.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2018 - 2028).
Report ID: Rn570744475 Published Date: July, 2022 Updated Date: August, 2022

Introduction

Global Prophylactic HIV Drugs Market (USD Million), 2018 - 2028

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2018 - 2028
2018 70.6
2019 75.5
2020 81.6
2021 82.1
2022 91.3
2023 104.0
2024 123.6
2025 141.2
2026 153.1
2027 182.8
2028 217.4

In the year 2021, the Global Prophylactic HIV Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drug
    2. Market Snapshot, By Dosage Form
    3. Market Snapshot, By Region
    4. Market Opportunity Map
  4. Global Prophylactic HIV Drugs Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising Prevalence of HIV/AIDS
        2. Increasing Government Initiatives
        3. Increasing Number of Blood Transfusions and Blood Donations
      2. Restraints
        1. Lower Penetration in Underdeveloped Market
      3. Opportunities
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Prophylactic HIV Drugs Market, By Drug, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Tenofovir
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Emtricitabine
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        3. Other
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    2. Global Prophylactic HIV Drugs Market, By Dosage Form, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Oral
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Topical
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    3. Global Prophylactic HIV Drugs Market, By Geography, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2028 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. APOTEX INC.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Auro Pharma Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Bristol-Myers Squibb Company
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. Cipla Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Genentech Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. Gilead Sciences Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. Johnson & Johnson Health Care Systems Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      8. Merck & Co. Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      9. Mylan NV
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      10. ViiV Healthcare Group of Companies
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Pharmaceuticals & Therapeutics Prostate Cancer Treatment
Global Prostate Cancer Treatment Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Prostate Cancer Treatment Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Prosthetic Heart Valve
Global Prosthetic Heart Valve Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Prosthetic Heart Valve Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Medical Devices Prosthetic Liners
Global Prosthetic Liners Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Prosthetic Liners Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Biotechnology Protein A Resin
Global Protein A Resin Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Protein A Resin Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...